Wedge Capital Management’s Boston Scientific BSX Stock Holding History

Wedge Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,764	Closed	-$213K	–	500
2024 Q2	$213K	Sell	2,764 -421	-13%	-$30.8K	﹤0.01%	478
2024 Q1	$218K	Buy	+3,185	New	+$205K	﹤0.01%	487
2017 Q1	–	Sell	-2,475,093	Closed	-$53.5M	–	558
2016 Q4	$53.5M	Buy	2,475,093 +368,496	+17%	+$8.04M	0.52%	46
2016 Q3	$50.1M	Sell	2,106,597 -29,417	-1%	-$702K	0.5%	56
2016 Q2	$49.9M	Sell	2,136,014 -134,785	-6%	-$2.92M	0.52%	53
2016 Q1	$42.7M	Buy	2,270,799 +88,099	+4%	+$1.55M	0.45%	56
2015 Q4	$40.2M	Sell	2,182,700 -177,250	-8%	-$3.18M	0.42%	69
2015 Q3	$38.7M	Sell	2,359,950 -89,600	-4%	-$1.53M	0.41%	62
2015 Q2	$43.4M	Buy	+2,449,550	New	+$43.8M	0.42%	79

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wedge Capital Management's BSX Position: Q3 2024 in Review

Wedge Capital Management sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 2,764 shares — an estimated $213K sold.

Wedge Capital Management first reported a position in BSX in Q2 2015 and held it in 9 quarters. The position peaked at $53.5M in Q4 2016. 1,401 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

Wedge Capital Management reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
Wedge Capital Management sold 2,764 Boston Scientific shares in Q3 2024, an estimated $213K.
Wedge Capital Management first reported a position in Boston Scientific in Q2 2015 and held it in 9 quarters.
Wedge Capital Management's Boston Scientific position peaked at $53.5M in Q4 2016.
1,401 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Wedge Capital Management's 13F filing for Q3 2024, filed 11 Oct 2024.